Fifth Third Bancorp’s Takeda Pharmaceutical TAK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$87.3K Buy
5,647
+415
+8% +$6.42K ﹤0.01% 1205
2025
Q1
$77.8K Buy
5,232
+2,411
+85% +$35.9K ﹤0.01% 1248
2024
Q4
$37.4K Buy
2,821
+619
+28% +$8.2K ﹤0.01% 1503
2024
Q3
$31.3K Buy
2,202
+128
+6% +$1.82K ﹤0.01% 1611
2024
Q2
$26.8K Sell
2,074
-551
-21% -$7.13K ﹤0.01% 1625
2024
Q1
$36.5K Buy
2,625
+691
+36% +$9.6K ﹤0.01% 1483
2023
Q4
$27.6K Hold
1,934
﹤0.01% 1652
2023
Q3
$29.9K Sell
1,934
-532
-22% -$8.23K ﹤0.01% 1567
2023
Q2
$38.7K Buy
2,466
+571
+30% +$8.97K ﹤0.01% 1465
2023
Q1
$31.2K Buy
1,895
+455
+32% +$7.5K ﹤0.01% 1644
2022
Q4
$22.5K Sell
1,440
-237
-14% -$3.7K ﹤0.01% 1659
2022
Q3
$22K Buy
1,677
+638
+61% +$8.37K ﹤0.01% 1657
2022
Q2
$15K Buy
1,039
+376
+57% +$5.43K ﹤0.01% 1863
2022
Q1
$9K Sell
663
-65
-9% -$882 ﹤0.01% 2105
2021
Q4
$10K Sell
728
-878
-55% -$12.1K ﹤0.01% 2104
2021
Q3
$26K Sell
1,606
-283
-15% -$4.58K ﹤0.01% 1696
2021
Q2
$32K Sell
1,889
-6,278
-77% -$106K ﹤0.01% 1628
2021
Q1
$149K Buy
8,167
+87
+1% +$1.59K ﹤0.01% 1041
2020
Q4
$147K Sell
8,080
-606
-7% -$11K ﹤0.01% 1033
2020
Q3
$155K Sell
8,686
-460
-5% -$8.21K ﹤0.01% 964
2020
Q2
$164K Sell
9,146
-1,871
-17% -$33.6K ﹤0.01% 934
2020
Q1
$167K Buy
11,017
+1,188
+12% +$18K ﹤0.01% 889
2019
Q4
$194K Buy
9,829
+509
+5% +$10K ﹤0.01% 953
2019
Q3
$160K Sell
9,320
-2,387
-20% -$41K ﹤0.01% 979
2019
Q2
$207K Sell
11,707
-3,018
-20% -$53.4K ﹤0.01% 904
2019
Q1
$300K Buy
14,725
+14,681
+33,366% +$299K ﹤0.01% 766
2018
Q4
$1K Buy
+44
New +$1K ﹤0.01% 2183